- Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma
[作者:Haller, DG; Rothenberg, ML; Wong, AO; Koralewski, PM; Miller, WH; Bodoky, G; Habboubi, N; Garay, C; Olivatto, LO,期刊:Journal of clinical oncology, 页码:4544-4550 , 文章类型: Article,,卷期:2008年26-28]
- PurposeTo determine whether irinotecan plus oxaliplatin (IROX) is superior to irinotecan alone in patients with metastatic colorectal cancer (CRC) previously treated with single-agent fluoropyrimidines.Patients and Metho...
- Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113
[作者:Ajani, JA; Winter, K; Komaki, R; Kelsen, DP; Minsky, BD; Liao, ZX; Bradley, J; Fromm, M; Hornback, D; Willett, CG,期刊:Journal of clinical oncology, 页码:4551-4556 , 文章类型: Article,,卷期:2008年26-28]
- PurposeTwo nonoperative approaches (one without fluorouracil) using induction chemotherapy and then definitive chemoradiotherapy developed at two centers were compared in patients with localized esophageal cancer (LEC). ...
- Association between hepatitis B virus and pancreatic cancer
[作者:Hassan, MM; Li, DH; El-Deeb, AS; Wolff, RA; Bondy, ML; Davila, M; Abbruzzese, JL,期刊:Journal of clinical oncology, 页码:4557-4562 , 文章类型: Article,,卷期:2008年26-28]
- PurposeHepatitis B virus (HBV) and hepatitis C virus (HCV) are considered to be hepatotropic and are a major cause of hepatocellular carcinoma. However, little is known about the role of HBV and HCV infection in other ma...
- Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven
[作者:Attard, G; Reid, AHM; Yap, TA; Raynaud, F; Dowsett, M; Settatree, S; Barrett, M; Parker, C; Martins, V; Folkerd, E; Clark, J; Cooper, CS; Kaye, SB; Dearnaley, D; Lee, G; de Bono, JS,期刊:Journal of clinical oncology, 页码:4563-4571 , 文章类型: Article,,卷期:2008年26-28]
- PurposeStudies indicate that castration-resistant prostate cancer (CRPC) remains driven by ligand-dependent androgen receptor (AR) signaling. To evaluate this, a trial of abiraterone acetate-a potent, selective, small-mo...
- Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma
[作者:Hahn, OM; Yang, C; Medved, M; Karczmar, G; Kistner, E; Karrison, T; Manchen, E; Mitchell, M; Ratain, MJ; Stadler, WM,期刊:Journal of clinical oncology, 页码:4572-4578 , 文章类型: Article,,卷期:2008年26-28]
- PurposeSorafenib is an antiangiogenic agent with activity in renal cancer. We conducted a randomized trial to investigate dynamic contrast magnetic resonance imaging (DCE-MRI) as a pharmacodynamic biomarker.Patients and ...
- Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: A Cancer and Leukemia Group B study
[作者:Neubauer, A; Maharry, K; Mrozek, K; Thiede, C; Marcucci, G; Paschka, P; Mayer, RJ; Larson, RA; Liu, ET; Bloomfield, CD,期刊:Journal of clinical oncology, 页码:4603-4609 , 文章类型: Article,,卷期:2008年26-28]
- PurposeRAS mutations occur in 12% to 27% of patients with acute myeloid leukemia (AML) and enhance sensitivity to cytarabine in vitro. We examined whether RAS mutations impact response to cytarabine in vivo.Patients and ...
- Bisphosphonate-related osteonecrosis of the jaws: A case-control study of risk factors in breast cancer patients
[作者:Kyrgidis, A; Vahtsevanos, K; Koloutsos, G; Andreadis, C; Boukovinas, I; Teleioudis, Z; Patrikidou, A; Triaridis, S,期刊:Journal of clinical oncology, 页码:4634-4638 , 文章类型: Article,,卷期:2008年26-28]
- PurposeOsteonecrosis of the jaws (ONJ) was initially described in 2001 in patients receiving intravenous bisphosphonate (BP) treatment. The objective of the present study was to determine whether routine dental procedure...
- Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study
[作者:Garmey, EG; Liu, Q; Sklar, CA; Meacham, LR; Mertens, AC; Stovall, MA; Yasui, Y; Robison, LL; Oeffinger, KC,期刊:Journal of clinical oncology, 页码:4639-4645 , 文章类型: Article,,卷期:2008年26-28]
- PurposeWe examined the rate of increase in the body mass index (BMI; kg/m(2)) after final height attainment in survivors of acute lymphoblastic leukemia (ALL) and a noncancer comparison group.MethodsChildhood Cancer Surv...
- Psychosocial factors and survival of young women with breast cancer: A population-based prospective cohort study
[作者:Phillips, KA; Osborne, RH; Giles, GG; Dite, GS; Apicella, C; Hopper, JL; Milne, RL,期刊:Journal of clinical oncology, 页码:4666-4671 , 文章类型: Article,,卷期:2008年26-28]
- PurposeMost women with early-stage breast cancer believe that psychosocial factors are an important influence over whether their cancer will recur. Studies of the issue have produced conflicting results.Patients and Meth...
- Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma
[作者:Marcus, R; Imrie, K; Solal-Celigny, P; Catalano, JV; Dmoszynska, A; Raposo, JC; Offner, FC; Gomez-Codina, J; Belch, A; Cunningham, D; Wassner-Fritsch, E; Stein, G,期刊:Journal of clinical oncology, 页码:4579-4586 , 文章类型: Article,,卷期:2008年26-28]
- PurposeTo compare the long-term outcome of patients with previously untreated follicular lymphoma (FL) needing therapy, after treatment with cyclophosphamide, vincristine and prednisone (CVP) versus CVP plus rituximab (R...
- Computed tomography response, but not positron emission tomography scan response, predicts survival after neoadjuvant chemotherapy for resectable non-small-cell lung cancer
[作者:Tanvetyanon, T; Eikman, EA; Sommers, E; Robinson, L; Boulware, D; Bepler, G,期刊:Journal of clinical oncology, 页码:4610-4616 , 文章类型: Article,,卷期:2008年26-28]
- PurposeTumor response is considered a surrogate marker of survival. We investigated whether tumor response based on computed tomography (CT) scan or whole-body [F-18] fluorodeoxyglucose positron emission tomography (PET)...
- Availability and use of palliative care and end-of-life services for pediatric oncology patients
[作者:Johnston, DL; Nagel, K; Friedman, DL; Meza, JL; Hurwitz, CA; Friebert, S,期刊:Journal of clinical oncology, 页码:4646-4650 , 文章类型: Article,,卷期:2008年26-28]
- PurposePalliative care prevents or relieves the symptoms caused by life-threatening medical conditions. Previous surveys have shown both underuse and lack of availability of these services for children with cancer throug...
- Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100
[作者:Schneider, BP; Wang, M; Radovich, M; Sledge, GW; Badve, S; Thor, A; Flockhart, DA; Hancock, B; Davidson, N; Gralow, J; Dickler, M; Perez, EA; Cobleigh, M; Shenkier, T; Edgerton, S; Miller, KD,期刊:Journal of clinical oncology, 页码:4672-4678 , 文章类型: Article,,卷期:2008年26-28]
- PurposeNo biomarkers have been identified to predict outcome with the use of an antiangiogenesis agent for cancer. Vascular endothelial growth factor ( VEGF) genetic variability has been associated with altered risk of b...
- Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
[作者:Fu, K; Weisenburger, DD; Choi, WWL; Perry, KD; Smith, LM; Shi, XL; Hans, CP; Greiner, TC; Bierman, PJ; Bociek, RG; Armitage, JO; Chan, WC; Vose, JM,期刊:Journal of clinical oncology, 页码:4587-4594 , 文章类型: Article,,卷期:2008年26-28]
- PurposeDiffuse large B-cell lymphoma (DLBCL) includes at least two prognostically important subtypes (ie, germinal center B-cell-like [GCB] and activated B-cell -like [ABC] DLBCL), which initially were characterized by g...
- Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data from 16 randomized controlled trials - NSCLC meta-analyses collaborative group
[作者:Burdett, S; Stephens, R; Stewart, L; Tierney, J; Auperin, A; Le Chevalier, T; Le Pechoux, C; Pignon, JP; Arriagada, R; Higgins, J; Johnson, D; van Meerbeeck, J; Parmar, M; Souhami, R,期刊:Journal of clinical oncology, 页码:4617-4625 , 文章类型: Article,,卷期:2008年26-28]
- PurposeSince our individual patient data (IPD) meta-analysis (MA) of supportive care and chemotherapy for non -small-cell lung cancer (NSCLC), published in 1995, many trials have been completed. An updated, IPD MA has be...
|